Meeting
2022 ASCO Genitourinary Cancers Symposium
Differentially expressed mRNA/proteins can distinguish viable germ cell tumors and teratomas from necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND).
Authors
Tim Nestler
Department of Urology and Uro-Oncology, University Hospital of Cologne, Cologne, Germany
Tim Nestler , Lara Kremer , Svenja Wagener-Ryczek , Maike Wittersheim , Melanie von Brandenstein , Pia Paffenholz , Stefan Mueller , Alexander Quaas , Martin Hellmich , Margarete Odenthal , David Pfister , Axel Heidenreich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 408)
DOI
10.1200/JCO.2022.40.6_suppl.408
Abstract #
408
Poster Bd #
D1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Validation of AGR2 and KRT19 as specific proteins being significantly and differentially expressed in teratoma compared to necrosis in retroperitoneal lymph node resections after chemotherapy (pcRPLND).
First Author: Tim Nestler
Poster
2022 ASCO Annual Meeting
Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT).
First Author: Jennifer King
Poster
2018 Genitourinary Cancers Symposium
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumor patients.
First Author: Ricardo Romao Nazario Leao
Poster
2012 ASCO Annual Meeting
Intraoperative detection of lymph node metastasis using one-step nucleic acid amplification (OSNA) in breast cancer patients: Effect on second surgery rate and delay for adjuvant therapy.
First Author: Sophie Klingler